Biomarkers related to interstitial lung disease encompass various types related to alveolar epithelial cell damage, fibroproliferation, extracellular matrix remodeling, and immune dysfunction (113), such as SP-D (114), KL-6 (115), and MMP-7 (116). Here, HOXD13 is linked to interstitial lung disease.